Method for rapidly identifying radix cyathulae and radix achyranthis bidentatae in Chinese patent medicine based on liquid chromatography-mass spectrometry

The determination of acne saponin I through liquid-mass synthesis technology solved the problem of identifying Chinese patent medicines Zhongchuan acne and acne saccharomyces, achieving rapid and accurate identification, and improving detection efficiency and accuracy.

CN119044341APending Publication Date: 2024-11-29SICHUAN PROVINCIAL INST FOR DRUG CONTROL (SICHUAN MEDICAL DEVICE TESTING CENT)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410936483.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-12
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The prior art cannot effectively distinguish and identify the Sichuan Ashdosaurus and Ashdosaurus in Chinese patent medicines, especially after the medicinal materials are crushed or extracted and processed, making it more difficult to identify.

Method used

By using liquid-mass fusion technology (UPLC-MS/MS) method, the presence and content of Achyranthes saponin I was determined, and combined with specific chromatography and mass spectrometry conditions were used to quickly identify whether Sichuan Achyranthes saccharomycephala and Macao were present in Chinese patent medicines. knee.

Benefits of technology

The rapid and accurate identification of the Chinese patent medicines Nakachuan Achyranthes and Ashdosaurus is achieved, which improves the identification efficiency and accuracy, and solves the problem that existing methods are difficult to identify mixed use or false.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044341A_ABST
    Figure CN119044341A_ABST
Patent Text Reader

Abstract

The invention discloses a method for rapidly identifying radix cyathulae and radix achyranthis bidentatae in a Chinese patent medicine based on a liquid chromatography-mass spectrometry technology. The method is used for identifying whether the radix cyathulae and the radix achyranthis bidentatae are adulterated or mixed in the Chinese patent medicine. The method can be widely applied to quality control and medicine supervision of Chinese patent medicines.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medical detection, and in particular to a method for rapidly identifying Chinese patent medicines Cyathula capitata and Cyathula capitata based on liquid chromatography-mass spectrometry technology. Background Art

[0002] Sichuan Cyathula is derived from the dried root of Cyathula officinalis Kuan, a plant of the Amaranthaceae family. It has the effects of removing blood stasis, promoting menstruation, promoting joints, promoting diuresis and relieving stranguria. It is used for amenorrhea, retained placenta, injuries from falls, rheumatism, pain in the feet, hematuria and stranguria. Ma Niuxi, also known as red Niuxi, is the dried root of Cyathula capitata (Wall.) Moq. of the Amaranthaceae family. It is a medicinal material used in Yi medicine clinically. It is mainly distributed in Liangshan Yi Autonomous Prefecture, Sichuan Province. It is called "Lebu" or "Naibu"; it is mainly used to treat gouty arthritis, cold-damp osteoarthritis, rheumatoid arthritis, rheumatoid arthritis and other diseases. Sichuan Cyathula is included in the 2020 edition of the "Chinese Pharmacopoeia" and is a genuine product. It is often mixed with a "bitter" type of Cyathula - Ma Niuxi. The clinical efficacy of Ma Niuxi is significantly different from that of Sichuan Cyathula. The distribution of Achyranthes bidentata is widespread in Sichuan Province. Its plant morphology is very similar to that of Achyranthes bidentata, making it difficult to distinguish. Achyranthes bidentata is often mixed with or used as Achyranthes bidentata. The detection method specified in the Part I of the 2020 edition of the Chinese Pharmacopoeia cannot effectively distinguish the two medicinal materials, especially when the Achyranthes bidentata in Chinese patent medicines has been processed by crushing or extraction, making identification even more difficult.

[0003] Studies have shown that Achyranthes bidentata saponin I (molecular formula: C48H76O18, CAS registration number: 51161-58-1) is a key indicator component for distinguishing Achyranthes bidentata from Rhizoma Cynoglossi. Given that its content is higher in Rhizoma Cynoglossi but not in Achyranthes bidentata, detecting the presence and content of Achyranthes bidentata saponin I in Chinese patent medicines provides a reliable means for effectively identifying these two medicinal materials in Chinese patent medicines. Considering that Chinese patent medicines are usually processed and mixed from many medicinal materials, each medicinal material contributes many chemical components, resulting in an extremely complex composition of the final product.

[0004] CN114460207A discloses a method for identifying Cyathula officinalis, which uses liquid chromatography technology to identify Cyathula officinalis in medicinal materials and decoction pieces. However, this method is not applicable to Chinese patent medicines with extremely complex ingredients.

[0005] Therefore, it is particularly important to develop a new method that can quickly and accurately identify Sichuan Achyranthes bidentata and Ma Achyranthes bidentata in traditional Chinese medicine. Summary of the invention

[0006] Based on the above problems, the present invention provides a method for quickly identifying Achyranthes bidentata and Achyranthes bidentata in Chinese patent medicines based on liquid chromatography-mass spectrometry technology, which can be widely used in quality control and drug supervision of Chinese patent medicines.

[0007] A method for rapidly identifying Cyathula capitata and Cyathula obtusifolia in Chinese patent medicines based on liquid chromatography-mass spectrometry technology, wherein the method is used to identify whether Cyathula capitata and Cyathula obtusifolia are adulterated or mixed in Chinese patent medicines.

[0008] In one or more specific embodiments of the present application, the following steps are included:

[0009] S1, pre-treatment of the sample to be tested to form a sample solution, the sample to be tested is a Chinese patent medicine nominally containing Cyathula capitata:

[0010] S2, preparing a solution of Achyranthes bidentata saponin I as a reference solution, wherein the reference solution is a solution of Achyranthes bidentata saponin I reference solution;

[0011] S3, using UPLC-MS / MS method to determine the sample solution and the Achyranthes bidentata saponin I reference solution, and obtaining chromatograms of the sample solution and the Achyranthes bidentata saponin I reference solution;

[0012] S4, compare the chromatogram peak areas of the sample solution and the reference solution of Achyranthes bidentata saponin I to identify the Achyranthes bidentata in the Chinese patent medicine;

[0013] S5, obtain the identification result.

[0014] In one or more specific embodiments of the present application, in S3, the chromatographic conditions are as shown in Table 1 below:

[0015] Table 1

[0016]

[0017] In one or more specific embodiments of the present application, in S3, the mass spectrometry conditions are: Agilent 6460 triple quadrupole mass spectrometer, the detection ion pairs are m / z 958.5→439.2 and m / z 958.5→191.1, the collision voltages are: 21V and 29V respectively; electrospray positive ion mode (ESI+), multiple reaction monitoring (MRM), drying gas temperature: 325°C; drying gas flow rate: 8L / min; sheath gas temperature: 350°C; sheath gas flow rate: 11L / min; capillary voltage: 3500V.

[0018] In one or more specific embodiments of the present application, the compound ion information is as shown in Table 2 below;

[0019] Table 2

[0020]

[0021]

[0022] .

[0023] In one or more specific embodiments of the present application, in S1, the sample pretreatment is: take 0.25 g of the mixed Chinese patent medicine sample, accurately weigh it, put it in a 150 ml stoppered conical flask, accurately add 25 ml of 30% methanol, seal it, weigh it, ultrasonically extract it for 45 minutes, take it out, cool it to room temperature, accurately weigh it again, make up the lost weight with 30% methanol, shake it well, filter it, and take the filtrate to obtain it.

[0024] In one or more specific embodiments of the present application, in S2, the concentrations of Achyranthes bidentata saponin I solution are 0.191 μg / ml, 1.911 μg / ml, and 7.644 μg / ml, respectively, and the solvent is methanol.

[0025] In one or more specific embodiments of the present application, the Chinese patent medicine is Tianma Qufeng Bupian, Tianzhi Granules, Qiangli Tianma Eucommia Capsules, Zhongfeng Huichun Tablets or Shenjin Huoluo Pills.

[0026] In one or more specific embodiments of the present application, in S4, during identification, if the sample solution extracted ion chromatogram shows a chromatographic peak with the same retention time as the reference solution extracted ion chromatogram, and the sample solution multiple reaction monitoring chromatographic peak area is larger than the reference solution multiple reaction monitoring chromatographic peak area, then it is judged that the Chinese medicine sample contains Cyathula capitata; otherwise, the Chinese medicine sample does not contain Cyathula capitata.

[0027] In one or more specific embodiments of the present application, the method: regression equation y=963.344931*x+102.679709, linear relationship R 2 =0.9995, x is the concentration of Achyranthes bidentata saponin I, ranging from 0.191 to 7.644 μg / ml; the specificity test shows that other medicinal flavors in the test sample formula except Achyranthes bidentata have no interference with the test results; the matrix effect experiment shows that the matrix effect has little effect on the test results; the instrument precision experiment RSD is 4.74%; the repeatability experiment RSD is 1.91%; the sample recovery RSD is 1.31%-1.86%; the sample stability RSD is 1.38%; the detection limit is 15 μg / g, and the quantification limit is 40 μg / g.

[0028] The beneficial effects of this application are:

[0029] 1. The identification method of the present invention has simple pre-treatment operation and short analysis time, and can quickly realize the identification of Cyathula officinalis in Chinese patent medicine, thereby improving the efficiency of identification;

[0030] 2. The present invention can quickly perform automated analysis on multiple samples, significantly improving the detection efficiency. At the same time, it can accurately identify specific components in complex Chinese patent medicine matrices, and has good selectivity and specificity, enhancing the accuracy of identification;

[0031] 3. The present invention can solve the problem that the existing methods are difficult to identify the mixing or adulteration of Sichuan Achyranthes bidentata and Ma Achyranthes bidentata in Chinese patent medicines. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 This is the MRM diagram of Achyranthes bidentata saponin I in the present invention;

[0033] Figure 2 This is a graph showing the results of the investigation of the extraction solvent of the present invention (peak area / sampling amount);

[0034] Figure 3 This is the MRM chromatogram of the reference solution of Example 6 of the present invention;

[0035] Figure 4 This is the MRM chromatogram of the negative matrix solution of Example 6 of the present invention;

[0036] Figure 5 This is the MRM chromatogram of the negative sample solution of Example 6 of the present invention;

[0037] Figure 6 It is the MRM chromatogram of the positive sample solution of Example 6 of the present invention;

[0038] Figure 7 is the standard curve of Achyranthes bidentata saponin I of Example 8 of the present invention;

[0039] Figure 8 This is the detection limit spectrum of Achyranthes bidentata saponin I of Example 12 of the present invention;

[0040] Fig. 9 The quantitative limit spectrum of Achyranthes bidentata saponin I of Example 12 of the present invention;

[0041] Fig.10 This is the MRM chromatogram of the Achyranthes bidentata saponin I sample solution of Example 13 of the present invention (Agilent Eclipse XDB-C18 2.1*100mm, 1.8μm);

[0042] Fig.11 This is the MRM chromatogram of the Achyranthes bidentata saponin I sample solution of Example 13 of the present invention (Agilent ZORBAX SB-C18 2.1*150mm, 1.8μm);

[0043] Fig.12This is the MRM chromatogram of the Achyranthes bidentata saponin I sample solution of Example 13 of the present invention (GL Sciences Inertsil ODS-3 2.1*150 mm, 2.0 μm);

[0044] Fig.13 This is the MRM chromatogram of the Achyranthes bidentata saponin I sample solution of Example 13 of the present invention (Waters ACQUITY UPLC BEH 2.1*100mm, 1.7μm);

[0045] Fig.14 This is the MRM chromatogram of the Achyranthes bidentata saponin I sample solution of Example 13 of the present invention (Thermo Hypersil GOLD 2.1*150mm, 1.9μm). DETAILED DESCRIPTION

[0046] The present invention will be further described below.

[0047] The embodiments provided in the present invention are only for further explaining the present invention and should not be construed as any limitation to the present invention.

[0048] It should be clear to those skilled in the art that, unless otherwise specified, the materials and operating methods used in the present invention are well known in the art.

[0049] In the following examples, the main instruments, reagents and software are as shown in Table 3;

[0050] Table 3

[0051]

[0052]

[0053] .

[0054] In the following examples, the standard substance information is shown in Table 4

[0055] Table 4

[0056]

[0057] In the following examples, the preparation of the reference solution is:

[0058] Accurately weigh 9.75 mg of Achyranthes bidentata saponin I (reference substance) and place it in a 25 ml volumetric flask. Add methanol to dissolve and dilute to the mark. Shake well to obtain a reference substance stock solution with a concentration of 382.2 μg / ml.

[0059] Accurately pipette 1 ml of Achyranthes bidentata saponin I reference substance stock solution into a 10 ml volumetric flask, dilute with methanol and make up to the mark, shake well to obtain the reference substance intermediate solution with a concentration of 38.22 μg / ml.

[0060] The MRM diagram of Achyranthes bidentata saponin Ⅰ is shown in Figure 1 shown.

[0061] In the following examples, the preparation of positive samples, negative samples, negative matrix samples and repetitive samples all adopt the same Chinese patent medicine formula containing Cyathula capitata:

[0062] Take a Chinese patent medicine formula containing Cyathula capitata, replace the Cyathula capitata with Cyathula capitata according to the prescribed amount, and then prepare it according to the preparation process of the Chinese patent medicine to obtain a positive sample.

[0063] Take a Chinese patent medicine formula containing Cyathula capitata, mix the prescription amounts of the remaining medicinal ingredients except Cyathula capitata, and then prepare it according to the preparation process of the Chinese patent medicine to obtain a negative sample.

[0064] A Chinese patent medicine formula containing Cyathula capitata was taken and prepared according to the preparation process of the Chinese patent medicine to obtain a negative matrix sample (ie, the Chinese patent medicine).

[0065] Take a Chinese patent medicine formula containing Cyathula capitata, replace part of Cyathula capitata with Cyathula capitata according to the prescribed amount, and obtain a reproducible sample.

[0066] Example 1 Selection of mobile phase

[0067] Methanol and acetonitrile were used as organic phases, and the retention and response of Achyranthes bidentata saponin I in different mobile phase systems were investigated with the same gradient, and the results are shown in Table 5. The results showed that the response of Achyranthes bidentata saponin I in the acetonitrile-0.1% formic acid solution (containing 5mmol / L ammonium formate) system was significantly better than that of methanol-0.1% formic acid solution (containing 5mmol / L ammonium formate), and the target peak and impurity peak in the acetonitrile system were well separated. Finally, acetonitrile-0.1% formic acid solution (containing 5mmol / L ammonium formate) was selected as the mobile phase for analysis.

[0068] Table 5 Mobile phase selection

[0069]

[0070]

[0071] The following Examples 2 to 5 are about the formation of sample solutions, wherein Examples 2 to 4 are about the selection of conditions, and Example 5 is about the formation of the sample solution determined by the present invention (i.e., the sample solution is formed by sample pretreatment).

[0072] Example 2 Selection of extraction solvent

[0073] Take 0.25g of the positive sample, weigh it accurately, and place it in 150ml conical flasks with stoppers. Accurately add 25ml each of 10% methanol, 30% methanol, 50% methanol, 80% methanol, and methanol, stopper it tightly, weigh it, treat it ultrasonically for 45min, take it out, cool it to room temperature, weigh it again, make up the lost weight with the corresponding solvent, shake it well, filter it, and take the filtrate to obtain it.

[0074] Accurately pipette 1 μl of each sample solution and inject it into the HPLC-MS instrument. Measure it according to the established conditions. The results are shown in Figure 2 .

[0075] from Figure 2 It can be seen from the results that the extraction efficiency is best when 30% methanol is used as the extraction solvent, so the extraction solvent is determined to be 30% methanol.

[0076] Example 3 Extraction method and time

[0077] Preparation of sample solution 1: Take 0.25 g of the positive sample, weigh it accurately, place it in a 150 ml conical flask with a stopper, accurately add 25 ml of 30% methanol, stopper it, weigh it, and treat it with ultrasound (power 250 W, frequency 40 kHz) for 30 min, 45 min, and 60 min, respectively. Take it out, cool it to room temperature, weigh it accurately again, make up the lost weight with 30% methanol, shake it well, filter it, and take the filtrate to obtain it.

[0078] Preparation of sample solution 2: Take 0.25 g of the positive sample, weigh it accurately, place it in a 150 ml conical flask with a stopper, accurately add 25 ml of 30% methanol, stopper it, weigh it, heat it under reflux for 30 min, 45 min, and 60 min, take it out, cool it to room temperature, weigh it accurately again, make up the lost weight with 30% methanol, shake it well, filter it, and take the filtrate to obtain the solution.

[0079] 1 μl of each of the above sample solutions was accurately pipetted and injected into a liquid chromatography-mass spectrometer. The measurement was performed according to the established conditions. The results are shown in Table 6.

[0080] Table 6 Results of extraction method (peak area / sampling amount)

[0081]

[0082] Based on the test results of Achyranthes bidentata saponin I, there was no significant difference in the efficiency of heating reflux extraction and ultrasonic extraction. In order to improve the experimental efficiency and operational convenience, ultrasonic extraction for 45 minutes was selected.

[0083] Example 4 Extraction solvent amount

[0084] Preparation of sample solution: Take 0.25g of positive sample, weigh accurately, and place in 150ml stoppered conical flasks, add 10ml, 25ml, and 50ml of 30% methanol accurately, stopper tightly, weigh the weight, and ultrasonically treat (power 250W, frequency 40kHz) for 45min, take out, cool to room temperature, weigh accurately again, make up the lost weight with 30% methanol, shake well, filter, and take the filtrate. Accurately take 1μl of the above sample solution, inject it into the liquid chromatography-mass spectrometer, and measure it according to the established conditions. The results are shown in Table 7.

[0085] Table 7 Extraction solvent amount results (peak area * solvent addition amount / sample amount)

[0086]

[0087] It can be seen from Table 7 that 25 ml of solvent is significantly higher than 10 ml of solvent, and there is no significant difference between 25 ml of solvent and 50 ml of solvent, indicating that 25 ml of solvent extraction can basically completely extract the target compound.

[0088] Example 5 Sample solution preparation method determined

[0089] Take 0.25 g of the mixed Chinese patent medicine sample, accurately weigh it, put it in a 150 ml conical flask with a stopper, accurately add 25 ml of 30% methanol, seal it, weigh it, perform ultrasonic extraction for 45 minutes, take it out, cool it to room temperature, accurately weigh it again, make up the lost weight with 30% methanol, shake it well, filter it, and take the filtrate to obtain the sample solution.

[0090] The present invention provides a method for quickly identifying Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry technology, comprising the following steps:

[0091] S1, sample pretreatment to form sample solution:

[0092] S2, preparing a solution of Achyranthes bidentata saponin I as a reference solution, wherein the reference solution is a solution of Achyranthes bidentata saponin I reference solution;

[0093] S3, using UPLC-MS / MS method to determine the sample solution and the Achyranthes bidentata saponin I reference solution, and obtaining chromatograms of the sample solution and the Achyranthes bidentata saponin I reference solution;

[0094] S4, compare the chromatogram peak areas of the sample solution and the reference solution of Achyranthes bidentata saponin I to identify the Achyranthes bidentata in the Chinese patent medicine;

[0095] S5, obtain the identification result.

[0096] Further, in S3, the chromatographic conditions are as shown in Table 1

[0097] Table 1

[0098]

[0099] Further, in S3, the mass spectrometry conditions are: Agilent 6460 triple quadrupole mass spectrometer, detection ion pairs are m / z 958.5→439.2 and m / z 958.5→191.1, collision voltages are: 21V and 29V respectively; electrospray positive ion mode (ESI+), multiple reaction monitoring (MRM), drying gas temperature: 325°C; drying gas flow rate: 8L / min; sheath gas temperature: 350°C; sheath gas flow rate: 11L / min; capillary voltage: 3500V, and compound ion information is as shown in Table 2 below;

[0100] Table 2

[0101]

[0102] Furthermore, in S1, the sample pretreatment is as follows: take 0.25 g of the mixed Chinese patent medicine sample, accurately weigh it, put it in a 150 ml stoppered conical flask, accurately add 25 ml of 30% methanol, seal it, weigh it, perform ultrasonic extraction for 45 minutes, take it out, cool it to room temperature, accurately weigh it again, make up the lost weight with 30% methanol, shake it well, filter it, and take the filtrate to obtain it.

[0103] Furthermore, in S2, the concentrations of Achyranthes bidentata saponin I solution were 0.191 μg / ml, 0.382 μg / ml, 0.764 μg / ml, 1.911 μg / ml, 3.822 μg / ml, and 7.644 μg / ml, respectively, and the solvent was methanol.

[0104] Furthermore, the Chinese patent medicine is Tianma Qufeng Bu Tablets, Tianzhi Granules, Qiangli Tianma Eucommia Capsules, Zhongfeng Huichun Tablets or Shenjin Huoluo Pills.

[0105] The following examples 6 to 15 are methodological investigation experiments.

[0106] In the following examples, the negative sample solution, negative matrix solution and positive sample solution were prepared as follows:

[0107] Preparation of negative sample solution: Take a negative sample, accurately weigh 0.25 g, and prepare a negative sample solution according to the sample solution preparation method (ie, the method of Example 5).

[0108] Preparation of negative matrix solution: Take a negative matrix sample, accurately weigh 0.25 g, and prepare a negative matrix solution according to the sample solution preparation method.

[0109] Preparation of positive sample solution: Take the positive sample, accurately weigh 0.25g, and prepare the positive sample solution according to the sample solution preparation method.

[0110] Preparation of solvent reference working solution: Accurately pipette 0.05ml, 0.5ml and 2ml of the intermediate solution of Achyranthes bidentata saponin I reference substance into 10ml volumetric flasks respectively, dilute with 30% methanol and make up to the scale, shake well to obtain solvent reference working solutions with concentrations of 0.191μg / ml, 1.911μg / ml and 7.644μg / ml respectively.

[0111] Preparation of matrix reference working solution: Accurately pipette 0.05ml, 0.5ml and 2ml of the intermediate solution of Achyranthes bidentata saponin I reference substance into 10ml volumetric flasks respectively, dilute with negative matrix solution and make up to the scale, shake well to obtain matrix reference working solutions with concentrations of 0.191μg / ml, 1.911μg / ml and 7.644μg / ml respectively.

[0112] Example 6 Specificity Test

[0113] 1 μl of each negative sample solution, negative matrix solution, positive sample solution and solvent reference substance working solution (1.911 μg / ml) were respectively taken and injected into the liquid chromatography-mass spectrometer, and the measurement was performed according to the chromatographic conditions and mass spectrometry conditions of the present invention. The results showed that in the positive sample chromatogram, there was a corresponding chromatographic peak at the same position as the reference substance chromatogram retention time, while there was no corresponding chromatographic peak in the negative matrix chromatogram. This indicates that other medicinal flavors in the prescription did not interfere with the measurement results. MRM chromatogram is shown in Figure 3 to Figure 6 .

[0114] Example 7 Matrix Effect

[0115] 1 μl of solvent reference working solution and matrix reference working solution of three concentrations (0.191 μg / ml, 1.911 μg / ml, 7.644 μg / ml) were respectively aspirated and injected into liquid chromatography-mass spectrometer. Each concentration was measured 6 times according to the established instrument conditions (i.e., the above-mentioned chromatography-mass spectrometry conditions). The ratio of the reference peak area in the matrix reference working solution to the peak area of ​​the solvent reference working solution was used to evaluate the matrix effect of Achyranthes bidentata saponin I in the negative matrix sample. The results are shown in Table 8.

[0116] Table 8 Matrix effect investigation results (peak area)

[0117]

[0118] It can be seen from Table 8 that the average matrix effect at concentrations of 0.191 μg / ml, 1.911 μg / ml, and 7.644 μg / ml is 102%, and the matrix effect is in the range of 90% to 110%, indicating that the matrix effect has little effect on the test results. Therefore, the solvent is selected to configure the standard curve and the external standard method is used for quantification.

[0119] Example 8 Linear Relationship

[0120] Preparation of a series of control solutions: Accurately pipette 5μl, 10μl, 20μl, 50μl, 100μl, and 200μl of the intermediate solution of Achyranthes bidentata saponin I reference substance, respectively, and place them in 1ml volumetric flasks, add 30% methanol to dilute to the scale, shake well, and obtain a series of control solutions with a concentration of 0.191μg / ml to 7.644μg / ml. Pipette 1μl of each series of control solutions, inject into the liquid chromatography-mass spectrometer, and measure according to the established conditions (the above-mentioned chromatography and mass spectrometry conditions), and draw a standard curve with concentration (μg / ml) as the horizontal axis and response as the vertical axis. The results are shown in Figure 7 , Table 9.

[0121] Table 9 Linear relationship

[0122]

[0123] Example 9 Instrument Precision

[0124] 1 μl of the solvent reference working solution (1.911 μg / ml) was aspirated and injected into the HPLC-MS / MS instrument. The measurement was performed 6 times in succession under the established conditions (the above-mentioned chromatographic and mass spectrometric conditions). The instrument precision was calculated and the results are shown in Table 10.

[0125] Table 10 Instrument precision

[0126]

[0127] Example 10 Repeatability

[0128] Take a repetitive sample, and prepare 6 sample solutions in parallel according to the sample solution preparation method of Example 5, and measure them according to the established instrument conditions (the above-mentioned chromatographic and mass spectrometric conditions). The results are shown in Table 11.

[0129] Table 11 Repeatability

[0130]

[0131]

[0132] This shows that this method has good repeatability.

[0133] Example 11 Sample recovery rate

[0134] Preparation of spiked samples: Take 0.25g of negative matrix sample, accurately weigh, and place 9 portions in 150ml stoppered conical bottles, accurately add 3 portions of reference stock solution (Achyranthes bidentata saponin I concentration is 382.2μg / ml), accurately add 25ml of 30% methanol, seal, weigh, ultrasonically treat (power 250W, frequency 40kHz) for 45min, take out, cool to room temperature, accurately weigh again, make up the lost weight with 30% methanol, shake well, filter, and take the filtrate. Determine and calculate the recovery rate according to the established conditions of the instrument (the above-mentioned chromatographic and mass spectrometric conditions), and the results are shown in Table 12.

[0135] Table 12 Sample recovery

[0136]

[0137] Example 12 Sample stability

[0138] The sample solution of Example 10 was sampled once every 4 hours to determine the concentration of the components contained therein. The test lasted for 24 hours to evaluate the stability of the sample solution during the test. The results showed that the sample solution had good stability within 24 hours and could meet the needs of the test. The results are shown in Table 13.

[0139] Table 13 Sample stability

[0140]

[0141]

[0142] Example 13 Detection Limit and Quantification Limit

[0143] Detection limit (LOD): When the concentration of Achyranthes bidentata saponin I is 0.15 μg / ml, the S / N of Achyranthes bidentata saponin I is about 3. The detection limit of Achyranthes bidentata saponin I of this method is calculated to be 15 μg / g. The MRM diagram is shown in Figure 8 .

[0144] Limit of quantification (LOQ): When the concentration of Achyranthes bidentata saponin I is 0.4 μg / ml, the S / N of Achyranthes bidentata saponin I is about 10. The limit of quantification of Achyranthes bidentata saponin I in this method is calculated to be 40 μg / g. Fig. 9 .

[0145] Example 14 Chromatographic column durability

[0146] Five different specifications of chromatographic columns were used for the test. The column information is shown in Table 14 and the typical chromatograms are shown in Figure 10 to Figure 14 .

[0147] Table 14 Durability chromatographic column specifications and models

[0148]

[0149] Results The chromatographic behavior of Achyranthes bidentata saponin Ⅰ was good, indicating that different specifications of chromatographic columns had no significant effect on the detection of Achyranthes bidentata saponin Ⅰ. The experimental conditions are widely applicable.

[0150] Example 15 Sample Determination

[0151] 136 batches of Chinese patent medicine samples from five manufacturers were tested according to the present invention, and the results are shown in Table 15.

[0152] Table 15 Determination results of the content of Achyranthes bidentata saponin I in Chinese patent medicine

[0153]

[0154]

[0155]

[0156]

[0157] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for rapid identification of Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry, characterized in that: This method is used to identify whether there is adulteration or mixing of Sichuan Achyranthes bidentata and Chinese Herba Cynanchum wilfordii in Chinese patent medicines.

2. The method for rapid identification of Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry technology according to claim 1, characterized in that: The following steps are involved: S1, pre-treating the sample to be tested to form a sample solution, wherein the sample to be tested is a Chinese patent medicine nominally containing Cyathula capitata; S2, preparing a solution of Achyranthes bidentata saponin I as a reference solution, wherein the reference solution is a solution of Achyranthes bidentata saponin I reference solution; S3, using UPLC-MS / MS method to determine the sample solution and the Achyranthes bidentata saponin I reference solution, and obtaining chromatograms of the sample solution and the Achyranthes bidentata saponin I reference solution; S4, compare the chromatogram peak areas of the sample solution and the reference solution of Achyranthes bidentata saponin I to identify the Achyranthes bidentata in the Chinese patent medicine; S5, obtain the identification result.

3. The method for rapid identification of Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry according to claim 2, characterized in that: In S3, the chromatographic conditions are as shown in Table 1: Table 1 4. The method for rapid identification of Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry according to claim 3, characterized in that: In S3, the mass spectrometry conditions were: Agilent 6460 triple quadrupole mass spectrometer, detection ion pairs were m / z 958.5→439.2 and m / z 958.5→191.1, collision voltages were 21 V and 29 V, respectively; electrospray positive ionization mode (ESI + ), multiple reaction monitoring (MRM), drying gas temperature: 325°C; drying gas flow rate: 8 L / min; sheath gas temperature: 350°C; sheath gas flow rate: 11 L / min; capillary voltage: 3500 V.

5. The method for rapid identification of Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry according to claim 4, characterized in that: The compound ion information is shown in Table 2 below; Table 2 6. The method for rapid identification of Chinese patent medicines Achyranthes bidentata and Achyranthes bidentata based on liquid chromatography-mass spectrometry according to any one of claims 1 to 5, characterized in that: In S1, the sample pretreatment is as follows: take 0.25 g of the mixed Chinese patent medicine sample, accurately weigh it, put it in a 150 ml stoppered conical flask, accurately add 25 ml of 30% methanol, seal it, weigh it, perform ultrasonic extraction for 45 minutes, take it out, cool it to room temperature, accurately weigh it again, make up the lost weight with 30% methanol, shake it well, filter it, and take the filtrate to obtain it.

7. The method for rapid identification of Chinese patent medicines Cyathula obtusifolia and Cyathula obtusifolia based on liquid chromatography-mass spectrometry according to any one of claims 1 to 6, characterized in that: In S2, the concentrations of Achyranthes bidentata saponin I solution were 0.191 μg / ml, 0.382 μg / ml, 0.764 μg / ml, 1.911 μg / ml, 3.822 μg / ml, and 7.644 μg / ml, respectively, and the solvent was methanol.

8. The method for rapid identification of Chinese patent medicines Cyathula obtusifolia and Cyathula obtusifolia based on liquid chromatography-mass spectrometry according to any one of claims 1 to 6, characterized in that: In S4, during identification, if the extracted ion chromatogram of the sample solution shows a chromatographic peak with the same retention time as the extracted ion chromatogram of the reference solution, and the multiple reaction monitoring chromatographic peak area of ​​the sample solution is larger than the multiple reaction monitoring chromatographic peak area of ​​the reference solution, then it is judged that the Chinese patent medicine sample contains Cyathula capitata; otherwise, the Chinese patent medicine sample does not contain Cyathula capitata.

9. The method for rapid identification of Chinese patent medicines Cyathula officinalis and Cyathula officinalis based on liquid chromatography-mass spectrometry according to any one of claims 1 to 8, characterized in that: This method: regression equation y = 963.344931*x + 102.679709, linear relationship R 2 =0.9995, x is the concentration of Achyranthes bidentata saponin I, ranging from 0.191 to 7.644 μg / ml; the specificity test shows that other medicinal flavors in the test sample formula except Achyranthes bidentata have no interference with the test results; the matrix effect experiment shows that the matrix effect has little effect on the test results; the instrument precision experiment RSD is 4.74%; the repeatability experiment RSD is 1.91%; the sample recovery RSD is 1.31%-1.86%; the sample stability RSD is 1.38%; the detection limit is 15 μg / g, and the quantification limit is 40 μg / g.

10. The method for rapid identification of Chinese patent medicines Cyathula obtusifolia and Cyathula obtusifolia based on liquid chromatography-mass spectrometry according to any one of claims 1 to 9, characterized in that: The Chinese patent medicines include Tianma Qufeng Bu Tablets, Tianzhi Granules, Qiangli Tianma Eucommia Capsules, Zhongfeng Huichun Tablets or Shenjin Huoluo Pills.